Shah, Neel <br/><br/>
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.  [electronic resource] 

 -  eLife  09 2017 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2050-084X 
<br/><br/><label>Standard No.: </label>10.7554/eLife.27861  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--pharmacology<br/>Animals<br/>Azepines<br/>Benzamides<br/>Cell Line, Tumor<br/>Chromatin Immunoprecipitation--methods<br/>Clustered Regularly Interspaced Short Palindromic Repeats<br/>Drug Resistance, Neoplasm--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Heterografts<br/>Humans<br/>Male<br/>Metabolism, Inborn Errors--metabolism<br/>Mice<br/>Nitriles<br/>Phenylthiohydantoin--analogs & derivatives<br/>Prostatic Neoplasms--pathology<br/>Receptors, Androgen--metabolism<br/>Receptors, Glucocorticoid--deficiency<br/>Sequence Analysis<br/>Signal Transduction--drug effects<br/>Triazoles